Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer

Benjamin H L Tan, Laura A Birdsell, Lisa Martin, Vickie E Baracos, Kenneth C H Fearon

Research output: Contribution to journalArticlepeer-review

Abstract

The average weight-losing pancreatic cancer patient undergoing palliative therapy is frequently overweight rather than underweight, and this can confound conventional measures used for risk stratification. The aim of this study was to evaluate if weight and body composition, specifically sarcopenia, assessed from diagnostic computed tomography (CT) scans, is of prognostic value in patients with pancreatic cancer. The nature and extent of tissue loss over subsequent months was also evaluated.
Original languageEnglish
Pages (from-to)6973-6979
Number of pages7
JournalClinical Cancer Research
Volume15
Issue number22
DOIs
Publication statusPublished - 2009

Keywords

  • Aged
  • Body Composition
  • Body Weight
  • Female
  • Humans
  • Male
  • Middle Aged
  • Obesity
  • Overweight
  • Pancreatic Neoplasms
  • Prognosis
  • Risk
  • Sarcopenia
  • Tomography, X-Ray Computed
  • Treatment Outcome

Fingerprint

Dive into the research topics of 'Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer'. Together they form a unique fingerprint.

Cite this